ReviewRadiology2021
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging:
Open access · greenAbstract readReview
In one paragraph
Review in Radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 2 pooled it
26.6field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
78 citing papers in PubMed, 2 syntheses or guidelines pooled it, 133 citations in OpenAlex.
- ESR Essentials: imaging of lymphoma-practice recommendations by the European Society of Oncologic Imaging.European radiology · 2025Guideline
- Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.European journal of cancer (Oxford, England : 1990) · 2021Pooled it
- Not Everything That Shines Is Gold: Reactive Lymphadenopathy After COVID-19 Vaccination in a Breast Cancer Survivor.Journal of general internal medicine · 2025Article
- Axillary Lymphadenopathy after COVID-19 Vaccination: Follow-up for Enlarged Lymph Nodes on MR Imaging.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025Article
- Role of COVID-19 Vaccine in the Management of Gynecologic Oncology Lymphadenopathies.International journal of environmental research and public health · 2024Observational
- Changes in Screening Test Volume in the National Breast and Cervical Cancer Early Detection Program during the COVID-19 Pandemic, 2020-2022.International journal of environmental research and public health · 2024Article
- Examination of iatrogenic FDG accumulation after COVID-19 vaccination.Annals of nuclear medicine · 2024Article
- Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy onEuropean journal of medical research · 2023Article
- Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: a single-centre experience in 285 women.La Radiologia medica · 2023Article
- Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy.European radiology · 2023Article
- Prolonged febrile illness following first dose of ChAdOx1.BMJ case reports · 2023Article
- European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision.Insights into imaging · 2023Article
- Article
- Bilateral Axillary Lymphadenopathy After COVID-19 Vaccine Presenting for Lymph Node Surgical Biopsy: A Case Report.Cureus · 2023Article
- NovelJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023Article
- Review
- Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature.Medicina (Kaunas, Lithuania) · 2023Review
- The Clinical Utility of Molecular Imaging in COVID-19: An Update.Seminars in nuclear medicine · 2023Review
- Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.Radiology · 2023Article
- Axillary Lymphadenopathy Associated With COVID-19 Vaccination: Updates and Recommendations.Journal of radiology nursing · 2022Review
18 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
16 authors at 1 institution in 1 country.
Anton S BeckerFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0001-8372-6496
Rocio Perez-JohnstonFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0001-9063-2615
Sona A ChikarmaneFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0001-7326-4312
Melissa M ChenFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0002-3274-2653
Maria El HomsiFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0002-8483-3653
Kimberly N FeiginFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0003-1400-6385
Katherine M GallagherFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0001-9830-4915
Ehab Y HannaFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0003-3241-2440
Marshall HicksFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0003-0727-8980
Ahmet T IlicaFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0002-8701-6042
Erica L MayerFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0001-5430-8957
Atul B ShinagareFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.
Randy YehFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0003-2945-5546
Marius E MayerhoeferFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0001-8786-8686
Hedvig HricakFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0003-2240-9694
H Alberto VargasFrom the Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room H-704, New York, NY 10065 (A.S.B., R.P.J., M.E.H., K.N.F., K.M.G., A.T.I., R.Y., M.E.M., H.H., H.A.V.); Department of Radiology, Brigham and Women's Hospital, Boston, Mass (S.A.C., A.B.S.); Departments of Imaging (S.A.C., A.B.S.) and Medical Oncology (E.L.M.), Dana-Farber Cancer Institute, Boston, Mass; and Division of Diagnostic Imaging (M.M.C., M.H.) and Department of Head and Neck Surgery (E.Y.H.), MD Anderson Cancer Center, Houston, Tex.ORCID 0000-0003-1169-133X
Memorial Sloan Kettering Cancer Center · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748
Abstract
Vaccination-associated adenopathy is a frequent imaging finding after administration of COVID-19 vaccines that may lead to a diagnostic conundrum in patients with manifest or suspected cancer, in whom it may be indistinguishable from malignant nodal involvement. To help the medical community address this concern in the absence of studies and evidence-based guidelines, this special report offers recommendations developed by a multidisciplinary panel of experts from three of the leading tertiary care cancer centers in the United States. According to these recommendations, some routine imaging examinations, such as those for screening, should be scheduled before or at least 6 weeks after the final vaccination dose to allow for any reactive adenopathy to resolve. However, there should be no delay of other clinically indicated imaging (eg, for acute symptoms, short-interval treatment monitoring, urgent treatment planning or complications) due to prior vaccination. The vaccine should be administered on the side contralateral to the primary or suspected cancer, and both doses should be administered in the same arm. Vaccination information-date(s) administered, injection site(s), laterality, and type of vaccine-should be included in every preimaging patient questionnaire, and this information should be made readily available to interpreting radiologists. Clear and effective communication between patients, radiologists, referring physician teams, and the general public should be considered of the highest priority when managing adenopathy in the setting of COVID-19 vaccination.
Indexed as
COVID-19COVID-19 VaccinesDiagnostic ImagingHumansLymphadenopathyPeriodicals as TopicRadiologySARS-CoV-2United StatesCOVID-19 Vaccines
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.